基本信息
浏览量:377
职业迁徙
个人简介
Michael A. Caligiuri, M.D., President of City of Hope National Medical Center and the Deana and Steve Campbell Physician-in-Chief Distinguished Chair, is a world-renowned physician, scientist, builder, innovator, leader and visionary at City of Hope.
A leading researcher in immunology, lymphoma and leukemia, Dr. Caligiuri dedicates himself to developing the next generation of cancer therapies, rapidly delivering them to patients and curing their disease. His research team is currently focused on bringing natural killer cellular therapies to patients with any form of cancer.
Dr. Caligiuri strives to employ an inclusive leadership style to foster greater collaboration across City of Hope and other institutions and optimize the patient care system to ensure the highest quality and safest patient experience. More than 1,000 patients have been treated on clinical trials developed or co-developed by Dr. Caligiuri.
He was elected to the National Academy of Medicine's Class of 2018 for his breakthrough discoveries in NK leukemia and cutaneous T cell lymphoma. He is also the past president of the American Association for Cancer Research, the world's largest cancer research organization with 40,000 members in 120 countries. In addition to serving as president of the AACR, he was also recently named a fellow of that organization.
Previously, Dr. Caligiuri worked as a physician, scientist and leader in the cancer program at The Ohio State University for 20 years. He was the CEO of The James Cancer Hospital and Solove Research Institute and directed The Ohio State University Comprehensive Cancer Center for 14 years, recruiting over 300 cancer physicians and scientists.
A leading researcher in immunology, lymphoma and leukemia, Dr. Caligiuri dedicates himself to developing the next generation of cancer therapies, rapidly delivering them to patients and curing their disease. His research team is currently focused on bringing natural killer cellular therapies to patients with any form of cancer.
Dr. Caligiuri strives to employ an inclusive leadership style to foster greater collaboration across City of Hope and other institutions and optimize the patient care system to ensure the highest quality and safest patient experience. More than 1,000 patients have been treated on clinical trials developed or co-developed by Dr. Caligiuri.
He was elected to the National Academy of Medicine's Class of 2018 for his breakthrough discoveries in NK leukemia and cutaneous T cell lymphoma. He is also the past president of the American Association for Cancer Research, the world's largest cancer research organization with 40,000 members in 120 countries. In addition to serving as president of the AACR, he was also recently named a fellow of that organization.
Previously, Dr. Caligiuri worked as a physician, scientist and leader in the cancer program at The Ohio State University for 20 years. He was the CEO of The James Cancer Hospital and Solove Research Institute and directed The Ohio State University Comprehensive Cancer Center for 14 years, recruiting over 300 cancer physicians and scientists.
研究兴趣
论文共 742 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Christoph Weigel, Haley L. Klimaszewski, Selamawit Addissie,Sarah Schlotter, Fode Tounkara, James P. Dugan,Bradley M. Haverkos, Lynda Villagomez,Mark Lustberg,Pierluigi Porcu,Timothy Voorhees,Michael A. Caligiuri,
Cancer Researchno. 7_Supplement (2024)
Zhenlong Li,Rui Ma, Hejun Tang,Jiamin Guo, Zahir Shah,Jianying Zhang, Ningyuan Liu, Shuai Cao,Guido Marcucci,David Artis,Michael A Caligiuri,Jianhua Yu
Cellno. 3 (2024): 624-641.e23
Cancer immunology research (2024)
Zahir Shah, Lei Tian, Zhixin Li, Lewei Jin,Jianying Zhang,Zhenlong Li,Tasha Barr, Hejun Tang,Mingye Feng,Michael A. Caligiuri,Jianhua Yu
Lei Tian, Victoria Chen,Tasha Barr,Zhiyao Li, Yuqing Chen, Jiaying Zhang,Michael A. Caligiuri,Jianhua Yu
Cancer Researchno. 6_Supplement (2024): 1318-1318
Zhenlong Li, Hejun Tang, Victoria Chen, Rui Ma,Jianying Zhang,Guido Marcucci,Jianhua Yu,Michael A Caligiuri
Research square (2023): 886
MOLECULAR THERAPYno. 4 (2023): 156-156
引用0浏览0引用
0
0
Wenjuan Dong,Jing Wang,Lei Tian,Jianying Zhang,Erik W Settles,Chao Qin, Daniel R Steinken-Kollath, Ashley N Itogawa,Kimberly R Celona,Jinhee Yi, Mitchell Bryant,Heather Mead,
Nature communicationsno. 1 (2023): 1936-1936
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn